Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 07, 2025 09:00 ET | Source: Quris Technologies

Quris-AI's Bio-AI Platform Integrated by Merck KGaA, Darmstadt, Germany for Preclinical Small Molecule Drug Safety Evaluation

BOSTON and TEL-AVIV, Israel, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Quris-AI, an artificial intelligence (AI) innovator disrupting the pharmaceutical arena, today announced that Merck KGaA, Darmstadt,...
October 29, 2024 07:00 ET | Source: Quris Technologies

Quris-AI Acquires Nortis

BOSTON and TEL AVIV, Israel, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Quris-AI (Quris), a leading Bio-AI company focused on revolutionizing the pharmaceutical drug development process, today announced the...
January 04, 2024 08:00 ET | Source: Quris Technologies

Former Biogen CEO Michel Vounatsos Joins Quris-AI Board

Former Biogen CEO Michel Vounatsos Joins Quris-AI Board; Yossi Ben Amram Appointed President as BioAI Innovator Continues to Expand
September 28, 2023 08:00 ET | Source: Quris Technologies

Merck KGaA, Darmstadt, Germany and Quris-AI Expand Collaboration

Merck KGaA and Quris-AI Expand Collaboration After a Successful Preclinical Study Assessed the Quris-AI BioAI Drug Safety Platform
March 02, 2023 07:00 ET | Source: Quris Technologies

Quris-AI Named to Fast Company’s Annual List of the World’s Most Innovative Companies for 2023

BOSTON and TEL-AVIV, Israel, March 02, 2023 (GLOBE NEWSWIRE) -- Quris-AI, has been named to Fast Company’s prestigious annual list of the World’s Most Innovative Companies for 2023. This year’s...
December 20, 2022 08:00 ET | Source: Quris Technologies

Quris Earns Additional Seed Investment Led by SoftBank Vision Fund 2

BOSTON and TEL-AVIV, Israel, Dec. 20, 2022 (GLOBE NEWSWIRE) -- Quris, an artificial intelligence (AI) innovator disrupting the pharmaceutical arena, today announced it has secured an additional $9...
February 10, 2022 00:00 ET | Source: Quris Technologies

Merck KGaA, Darmstadt, Germany, Enters into Option Agreement with Quris on its BioAI Platform for Clinical Safety Prediction

BOSTON and TEL-AVIV, Israel, Feb. 10, 2022 (GLOBE NEWSWIRE) -- Quris, an artificial intelligence (AI) innovator disrupting the pharmaceutical arena, today announced it has signed an agreement with...